# Biovantix Biotechnology, Inc — Form D

Biovantix Biotechnology, Inc of DOVER, DE, a company, filed a Form D exempt-offering notice with the SEC on 2025-10-17. The offering totals $15.0M. Industry: Biotechnology.

## Offering

- Filed: 2025-10-17
- Form: D
- Accession: 0001683168-25-007630
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $15.0M
- Remaining: $15.0M
- Minimum investment: $10K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-561294

## Issuer

- Name: Biovantix Biotechnology, Inc
- CIK: 0002092174
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2025
- Address: 8 THE GREEN STE A, DOVER, DE, 19901
- Phone: 714-365-2391

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Christian Carnes | Executive Officer | Dover, DE |
| Jack Sunier | Executive Officer | Dover, DE |
| Elena Verutina | Executive Officer | Dover, DE |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-10-17](https://search.stillhousedata.com/formd/0001683168-25-007628) | D | $15.0M | — |

## More

- [CIK 2092174 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2092174&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001683168-25-007630.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.